AMA CPT® Assistant - 2005 Issue 2 (February)
Appendix I (February 2005)
February 2005 page 15 Coding Consultation:Questions and Answers Appendix I, (Q&A) Question What is the rationale behind the addition of Appendix I, new to CPT 2005? AMA Comment In an effort to address advances in technology, capture specific data for tracking utilization, and provide diagnostic granularity and specific information to allow payers to adjudicate claims for such analyses, a list of genetic testing modifiers has been added as Appendix I of CPT 2005. This numeric-alpha modifier coding system is arranged in a hierarchical system with the first (numeric) character indicating the disease type and the second (alpha) character...
Subscribe or sign in to view the full article.
Article Overview
This article is a brief CPT Assistant question-and-answer piece about a new appendix added in CPT 2005. It discusses the broader rationale for the appendix, its role in supporting molecular genetics reporting, and the related reporting guidance referenced in the pathology and laboratory sections. It is useful for coders, billers, and compliance staff who work with CPT updates affecting genetics and laboratory documentation.
Why This Topic Matters
The article helps readers understand why CPT 2005 introduced a new appendix and how that change ties into genetics-related reporting structure. It is relevant to professionals tracking code-set updates and documentation requirements in molecular diagnostic and cytogenetic services.
What You Will Learn
- Why a new CPT appendix was introduced in 2005
- How the appendix relates to genetics-related reporting
- Which CPT areas reference the new reporting guidance
- The general purpose of the appendix within the code set
Who Should Read This
- Medical coders
- Billing staff
- Compliance teams
- Laboratory coding specialists
- Pathology and laboratory professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
